We have previously shown that MDSCs are recruited to advanced melanoma lesions of the tg(Grm1)EPv mice and that these MDSCs are able to inhibit gp100-specific CD8+ T cell responses.21 In the present study, we examined how antitumor immune responses are impaired at the interface between early and advanced tumor stages. Here, CD8A is linked to melanoma.